Cyclerion Therapeutics, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
MA
Business Address
301 BINNEY STREET, CAMBRIDGE, MA, 02142
Mailing Address
301 BINNEY STREET, CAMBRIDGE, MA, 02142
Phone
617-621-7722
Fiscal Year End
1231
EIN
831895370
Financial Overview
FY2025 FY
$2.07M
Revenue
-$3.06M
Net Income
$9.98M
Total Assets
$9.09M
Stockholders' Equity
$3.24M
Cash & Equivalents
$-1.11
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | April 1, 2026 | View on SEC |
| 10-K Annual financial report | March 31, 2026 | View on SEC |
| 8-K Current report of material events | February 17, 2026 | View on SEC |
| 8-K Current report of material events | January 6, 2026 | View on SEC |
| 8-K Current report of material events | December 1, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 12, 2025 | View on SEC |
| 10-K/A Annual report amendment | November 12, 2025 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | October 17, 2025 | View on SEC |
| 8-K Current report of material events | September 23, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | August 14, 2025 | View on SEC |
Annual Reports
10-K
March 31, 2026
- Transitioned to a lean licensing-focused business model to generate cash.
- Successfully raised $8.5 million through a private stock sale in March 2025.
Material Events
8-K
Acquisition
April 1, 2026
High Impact
- Reverse merger with Korsana Biosciences to pivot into a clinical-stage growth company
- Secured $380 million in new private funding to fuel Phase 2 clinical trials
8-K
Other
February 17, 2026
High Impact
- Positive FDA feedback for lead asset CYC-126, reducing regulatory risk for Phase 2 study design.
- CYC-126 targets Treatment Resistant Depression (TRD), a significant unmet medical need.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.